111 552

Cited 41 times in

Which CT perfusion parameter best reflects cerebrovascular reserve?: correlation of acetazolamide-challenged CT perfusion with single-photon emission CT in Moyamoya patients.

Rim, NJ; Kim, HS; Shin, YS; Kim, SY
AJNR. American journal of neuroradiology, 29(9):1658-1663, 2008
Journal Title
AJNR. American journal of neuroradiology
BACKGROUND AND PURPOSE: CT perfusion (CTP) is a more readily accessible method for evaluation of cerebral perfusion than single-photon emission CT (SPECT). We assessed whether there is any resting or drug-challenged CTP parameter correlating with cerebrovascular reserve (CVR) obtained by SPECT in Moyamoya patients.

MATERIALS AND METHODS: Normalized baseline CTP parameters and their percentage changes were calculated in 152 regions of interest (ROIs). On qualitative SPECT analysis, each ROI was classified in either the "impaired CVR" or "normal CVR" group. Quantitative CVR was calculated by using normalized SPECT values before and after acetazolamide administration. Baseline CTP parameters and their percentage changes were compared with qualitative and quantitative CVRs. Receiver operating characteristic (ROC) curve analysis defined the threshold values of CTP parameters that best predict impaired qualitative CVR.

RESULTS: The mean values of CTP parameters were significantly different between normal and impaired CVR groups. The percentage change of cerebral blood flow (pcCBF) was correlated most significantly with quantitative CVR (r = 0.89; P < .05). The correlation coefficients between the baseline CTP parameters and quantitative CVR were poor or not significant. The ROC-derived threshold values of pcCBF and mean transit time determined impaired CVR with a sensitivity of 94.4 and 85.2; specificity of 93.2 and 65.9; positive predictive value of 97.1 and 86.0; and negative predictive value of 87.2 and 64.4, respectively.

CONCLUSION: Baseline CTP parameters are not reliable for predicting impaired CVR. However, pcCBF correlated strongly with quantitative CVR; therefore, CTP evaluation for CVR in Moyamoya patients requires normalization and acetazolamide challenge.
MeSH terms
Acetazolamide/diagnostic use*AdultAgedBlood Flow Velocity/physiologyBlood Volume/physiologyCarbonic Anhydrase Inhibitors/diagnostic use*Cerebral Angiography*Cerebral Arteries/physiopathologyCerebrovascular Circulation/physiology*Cysteine/analogs & derivativesCysteine/diagnostic useFemaleHumansImage Processing, Computer-AssistedMaleMiddle AgedMoyamoya Disease/diagnosisMoyamoya Disease/physiopathology*Organotechnetium Compounds/diagnostic usePerfusion Imaging*Reference ValuesSensitivity and SpecificityTomography, Emission-Computed, Single-Photon*Tomography, X-Ray Computed*
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Radiology
AJOU Authors
김, 호성김, 선용
Full Text Link
Files in This Item:
RIS (EndNote)
XLS (Excel)


해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.